Clinical trial
Restless Legs Syndrome in Hemodialysis Patients: Prevalence, Associated Risk Factors and Efficacy of Vitamin C as a Treatment
NCT03337529 is registered in ClinicalTrials.gov with Makassed General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Restless Legs Syndrome in Hemodialysis Patients: Prevalence, Associated Risk Factors and Efficacy of Vitamin C as a Treatment
- Lead sponsor
- Makassed General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2017
- Completion date
- April 15, 2018
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
restless leg syndrome